A

Acer Therapeutics Inc
F:P6NA

Watchlist Manager
Acer Therapeutics Inc
F:P6NA
Watchlist
Price: 0.804 EUR Market Closed
Market Cap: 28.8m EUR

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of P6NA.

The Intrinsic Value is calculated as the average of DCF and Relative values:

P6NA Intrinsic Value
Not Available
A
Base Case Scenario
Compare P6NA to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Contacts
Loading...
How do you feel about P6NA?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Acer Therapeutics Inc

Current Assets 3.5m
Cash & Short-Term Investments 2.3m
Other Current Assets 1.2m
Non-Current Assets 8.1m
PP&E 414.6k
Intangibles 7.6m
Other Non-Current Assets 45.7k
Current Liabilities 19m
Accounts Payable 3.8m
Accrued Liabilities 3.7m
Other Current Liabilities 11.5m
Non-Current Liabilities 9.4m
Long-Term Debt 9.3m
Other Non-Current Liabilities 145.7k
Efficiency

Free Cash Flow Analysis
Acer Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Acer Therapeutics Inc

Revenue
0 USD
Operating Expenses
-24.6m USD
Operating Income
-24.6m USD
Other Expenses
-1.6m USD
Net Income
-26.2m USD
Fundamental Scores

P6NA Profitability Score
Profitability Due Diligence

Acer Therapeutics Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

Exceptional ROE
ROIC is Increasing
Low 3Y Average Gross Margin
Negative 3Y Average Net Margin
32/100
Profitability
Score

Acer Therapeutics Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

P6NA Solvency Score
Solvency Due Diligence

Acer Therapeutics Inc's solvency score is 26/100. The higher the solvency score, the more solvent the company is.

Low D/E
Negative Net Debt
Long-Term Solvency
Short-Term Solvency
26/100
Solvency
Score

Acer Therapeutics Inc's solvency score is 26/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

P6NA Price Targets Summary
Acer Therapeutics Inc

There are no price targets for P6NA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Acer Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for P6NA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y